These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16265538)

  • 21. Hypertrophy and fibrosis in the cardiomyopathy of uremia--beyond coronary heart disease.
    Gross ML; Ritz E
    Semin Dial; 2008; 21(4):308-18. PubMed ID: 18627569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment.
    Ramaraj R
    Cardiol Rev; 2008; 16(4):172-80. PubMed ID: 18562807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selected mutations in the myosin binding protein C gene in the Polish population of patients with hypertrophic cardiomyopathy.
    Rudziński T; Selmaj K; Drozdz J; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Aug; 66(8):821-5; discussion 826-7. PubMed ID: 18803133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease.
    Charron P; Komajda M
    Expert Rev Mol Diagn; 2006 Jan; 6(1):65-78. PubMed ID: 16359268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.
    Alcalai R; Seidman JG; Seidman CE
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):104-10. PubMed ID: 17916152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
    Dereure O
    Ann Dermatol Venereol; 2008; 135(8-9):624-5. PubMed ID: 18789305
    [No Abstract]   [Full Text] [Related]  

  • 27. The search of 'novel' mtDNA mutations in hypertrophic cardiomyopathy: MITOMAPping as a risk factor.
    Bandelt HJ; Yao YG; Salas A
    Int J Cardiol; 2008 Jun; 126(3):439-42. PubMed ID: 17482693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy.
    Capek P; Brdicka R
    Cas Lek Cesk; 2006; 145(2):93-6; discussion 96-7. PubMed ID: 16521396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?
    Bos JM; Ommen SR; Ackerman MJ
    Curr Opin Cardiol; 2007 May; 22(3):193-9. PubMed ID: 17413275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic contributions of physicians--the financial impact on their community.
    Rotarius T; Liberman A; Trujillo A
    Health Care Manag (Frederick); 2008; 27(4):317-23. PubMed ID: 19011414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Access to dental care among adults with physical and intellectual disabilities: residence factors.
    Pradhan A; Slade GD; Spencer AJ
    Aust Dent J; 2009 Sep; 54(3):204-11. PubMed ID: 19709107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apical hypertrophic cardiomyopathy mimicking acute coronary syndrome: a case report and review of the literature.
    Olearczyk B; Gollol-Raju N; Menzies DJ
    Angiology; 2008; 59(5):629-31. PubMed ID: 18388083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertrophic cardiomyopathy and the Hypertrophic Cardiomyopathy Association.
    Salberg L
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():3-4. PubMed ID: 17162262
    [No Abstract]   [Full Text] [Related]  

  • 36. Heart transplantation in hypertrophic cardiomyopathy.
    Biagini E; Spirito P; Leone O; Picchio FM; Coccolo F; Ragni L; Lofiego C; Grigioni F; Potena L; Rocchi G; Bacchi-Reggiani L; Boriani G; Prandstraller D; Arbustini E; Branzi A; Rapezzi C
    Am J Cardiol; 2008 Feb; 101(3):387-92. PubMed ID: 18237606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis.
    Nair AG; Fischer AG
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():40-3. PubMed ID: 17162269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic cardiomyopathy in the black population of South Africa.
    Colyn HJ; Kleynhans PH
    S Afr Med J; 1990 Feb; 77(3):165. PubMed ID: 2305326
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypertrophic cardiomyopathy in a patient with Down's syndrome.
    Assenza GE; Autore C; Marino B
    J Cardiovasc Med (Hagerstown); 2007 Jun; 8(6):463-4. PubMed ID: 17502765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.
    Monserrat L; Gimeno-Blanes JR; Marín F; Hermida-Prieto M; García-Honrubia A; Pérez I; Fernández X; de Nicolas R; de la Morena G; Payá E; Yagüe J; Egido J
    J Am Coll Cardiol; 2007 Dec; 50(25):2399-403. PubMed ID: 18154965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.